HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Animal models for aberrations of gonadotropin action.

Abstract
During the last two decades a large number of genetically modified mouse lines with altered gonadotropin action have been generated. These mouse lines fall into three categories: the lack-of-function mice, gain-of-function mice, and the mice generated by breeding the abovementioned lines with other disease model lines. The mouse strains lacking gonadotropin action have elucidated the necessity of the pituitary hormones in pubertal development and function of gonads, and revealed the processes from the original genetic defect to the pathological phenotype such as hypo- or hypergonadotropic hypogonadism. Conversely, the strains of the second group depict consequences of chronic gonadotropin action. The lines vary from those expressing constitutively active receptors and those secreting follicle-stimulating hormone (FSH) with slowly increasing amounts to those producing human choriogonadotropin (hCG), amount of which corresponds to 2000-fold luteinizing hormone (LH)/hCG biological activity. Accordingly, the phenotypes diverge from mild anomalies and enhanced fertility to disrupted gametogenesis, but eventually chronic, enhanced and non-pulsatile action of both FSH and LH leads to female and male infertility and/or hyper- and neoplasias in most of the gonadotropin gain-of-function mice. Elevated gonadotropin levels also alter the function of several extra-gonadal tissues either directly or indirectly via increased sex steroid production. These effects include promotion of tumorigenesis in tissues such as the pituitary, mammary and adrenal glands. Finally, the crossbreedings of the current mouse strains with other disease models are likely to uncover the contribution of gonadotropins in novel biological systems, as exemplified by the recent crossbreed of LHCG receptor deficient mice with Alzheimer disease mice.
AuthorsHellevi Peltoketo, Fu-Ping Zhang, Susana B Rulli
JournalReviews in endocrine & metabolic disorders (Rev Endocr Metab Disord) Vol. 12 Issue 4 Pg. 245-58 (Dec 2011) ISSN: 1573-2606 [Electronic] Germany
PMID21484328 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Gonadotropins
Topics
  • Animals
  • Disease Models, Animal
  • Endocrine System Diseases (genetics, metabolism, pathology, physiopathology)
  • Female
  • Gonadotropins (deficiency, genetics, metabolism, physiology)
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Ovary (metabolism, pathology, physiology)
  • Pituitary Gland (metabolism, pathology, physiology)
  • Testis (metabolism, pathology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: